Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BMY vs GSK✓SelectedUSD · GSKBMY vs GSK performance historyLatest closeAs of-2.51%11/17
Stock and ETF performance explorer

BMY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+54.5%
GSK return
+104.0%
Excess return
-49.5%
Maximum drawdown
-47.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.5%-2.3%-0.2%-1.5%
7D-2.3%-3.0%+0.7%-0.9%
30D+2.7%+0.4%+2.3%+2.5%
3M-4.1%-1.2%-2.9%-3.6%
6M+10.0%+0.9%+9.0%+9.5%
YTD+18.8%+4.0%+14.8%+16.5%
1Y+36.9%+7.3%+29.6%+32.5%
3Y+39.0%+57.1%-18.1%+12.1%
5Y+26.9%+43.0%-16.0%+4.6%
10Y+54.5%+103.1%-48.6%+1.4%
All+54.5%+104.0%-49.5%+1.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling